Literature DB >> 33392477

Testicular sperm extraction in a patient with ejaculatory dysfunction after combined androgen blockade therapy for prostate cancer.

Toshiyasu Amano1, Chihiro Suzuki1, Yuji Shimojima1, Tetsuya Imao1, Carolyn Earle2.   

Abstract

INTRODUCTION: Prostate cancer is the most prevalent urological cancer for older men. However, there is still a possibility that a few prostate cancer patients may still wish to have children. CASE
PRESENTATION: A 49-year-old male was diagnosed with low-risk prostate cancer. Combined anti-androgen blockade therapy was performed for 8 months prior to radiation therapy. However, he suffered from ejaculatory dysfunction and wished to conceive with his partner. Hormonal therapy was discontinued and he was referred to our clinic for sperm preservation. His ejaculatory function did not recover after 4 months discontinuation of hormonal therapy, subsequently micro-testicular sperm extraction for sperm preservation was successfully performed.
CONCLUSION: Sperm preservation in patients with prostate cancer is unusual but it should be considered if the patient's fertility is an issue.
© 2020 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.

Entities:  

Keywords:  combined androgen blockade therapy; ejaculatory dysfunction; prostate cancer; sperm preservation; testicular sperm extraction

Year:  2020        PMID: 33392477      PMCID: PMC7770593          DOI: 10.1002/iju5.12176

Source DB:  PubMed          Journal:  IJU Case Rep        ISSN: 2577-171X


  8 in total

1.  Oncological outcomes of the prostate cancer patients registered in 2004: report from the Cancer Registration Committee of the JUA.

Authors:  Hiroyuki Fujimoto; Hiroyuki Nakanishi; Tsuneharu Miki; Yoshinobu Kubota; Satoru Takahashi; Kazuhiro Suzuki; Hiro-omi Kanayama; Kazuya Mikami; Yukio Homma
Journal:  Int J Urol       Date:  2011-12       Impact factor: 3.369

2.  Sperm banking is of key importance in patients with prostate cancer.

Authors:  Andrea Salonia; Paolo Capogrosso; Fabio Castiglione; Andrea Russo; Andrea Gallina; Matteo Ferrari; Maria Chiara Clementi; Giulia Castagna; Alberto Briganti; Francesco Cantiello; Rocco Damiano; Francesco Montorsi
Journal:  Fertil Steril       Date:  2013-05-04       Impact factor: 7.329

Review 3.  Male infertility in cancer patients: Review of the literature.

Authors:  Gert R Dohle
Journal:  Int J Urol       Date:  2010-02-22       Impact factor: 3.369

Review 4.  Endocrine treatment of prostate cancer.

Authors:  Teuvo Tammela
Journal:  J Steroid Biochem Mol Biol       Date:  2004-12-31       Impact factor: 4.292

5.  Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment.

Authors:  Buffi G Boyd; Stewart W McCallum; Ronald W Lewis; Martha K Terris
Journal:  Urology       Date:  2006-10       Impact factor: 2.649

6.  Successful sperm extraction and live birth after radiation, androgen deprivation and surgical castration for treatment of metastatic prostate cancer.

Authors:  G J A Wood; R P Hayden; C Tanrikut
Journal:  Andrologia       Date:  2016-04-06       Impact factor: 2.775

Review 7.  The cycle of the seminiferous epithelium in humans: a need to revisit?

Authors:  Rupert P Amann
Journal:  J Androl       Date:  2008-05-22

8.  Semen cryopreservation as an oncofertility treatment in 122 Japanese men with cancer: A decade-long study.

Authors:  Hideyuki Kobayashi; Koji Tamura; Toshihiro Tai; Koichi Nagao; Koichi Nakajima
Journal:  Reprod Med Biol       Date:  2017-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.